Bluefin Capital Management, LLC Teva Pharmaceutical Industries LTD Transaction History

Bluefin Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $111,687 - $143,075	-15,237 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $213,300 - $275,130	-27,000 Reduced 63.92%	15,237 $122,000
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $92,180 - $111,980	-11,000 Reduced 20.66%	42,237 $411,000
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $263,340 - $307,496	26,600 Added 99.86%	53,237 $527,000
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $275,426 - $341,219	26,637 New	26,637 $307,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.